1 Growth Stock Set to Flourishand 2 We Avoid [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Deciphering which businesses can sustain their high growth rates is a challenge for even the most seasoned professionals, which is why we started StockStory. That said, here is one growth stock expanding its competitive advantage and two that could be down big. One-Year Revenue Growth: +30.4% Pioneering the field of "liquid biopsy" with technology that can identify cancer-specific genetic mutations from a simple blood draw, Guardant Health (NASDAQ:GH) develops blood tests that detect and monitor cancer by analyzing tumor DNA in the bloodstream, helping doctors make treatment decisions without invasive biopsies. Why Do We Think Twice About GH? Revenue growth over the past five years was nullified by the company's new share issuances as its earnings per share fell by 18.5% annually Cash-burning history makes us doubt the long-term viability of its business model Unprofitable operations could lead to additional rounds of dilutive equity financing if the credit window closes
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart PlatformBusiness Wire
- Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth [Seeking Alpha]Seeking Alpha
- Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 ResultsBusiness Wire
- How Recent Analyst Targets Are Shaping The Evolving Story For Guardant Health (GH) [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 1/16/26 - Form 4
- 1/16/26 - Form 4
- 1/12/26 - Form 8-K
- GH's page on the SEC website